Singapore markets closed

Alector, Inc. (ALEC)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
4.3100+0.1200 (+2.86%)
As of 10:51AM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close4.1900
Open4.3000
Bid3.0700 x 200
Ask5.5000 x 200
Day's range4.2400 - 4.4695
52-week range3.6600 - 9.0650
Volume184,518
Avg. volume588,282
Market cap415.418M
Beta (5Y monthly)0.77
PE ratio (TTM)N/A
EPS (TTM)-1.3900
Earnings date01 Aug 2024 - 05 Aug 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est13.75
  • GlobeNewswire

    Alector to Participate in the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference

    SOUTH SAN FRANCISCO, Calif., June 20, 2024 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company pioneering immuno-neurology, today announced that management will participate in a corporate presentation at the H.C. Wainwright 5th Annual Neuro Perspectives Conference, being held virtually on Thursday, June 27, 2024. A webcast of the presentation will be available on the “Events & Presentations” page at 7:00 a.m. ET within the Investors section of the Alector web

  • GlobeNewswire

    Alector to Host Virtual Research and Development Event Highlighting Alector Brain Carrier Blood-Brain Barrier Technology Platform

    Leading scientific expert to provide insights into emerging technologies for blood-brain barrier modulationSOUTH SAN FRANSISCO, Calif., June 10, 2024 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company pioneering immuno-neurology, today announced management will host a virtual event to discuss Alector Brain Carrier, a proprietary, versatile blood-brain barrier (BBB) technology platform that is being applied selectively to the Company’s next-generation product

  • GlobeNewswire

    Alector to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

    SOUTH SAN FRANCISCO, Calif., June 03, 2024 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company pioneering immuno-neurology, today announced that management will participate in a fireside chat at the Goldman Sachs 45th Annual Global Healthcare Conference on Monday, June 10, 2024, at 1:20 p.m. ET. A live webcast of the fireside chat will be available on the “Events & Presentations” page within the Investors section of the Alector website at http://investors.ale